Valganciclovir Tablets Recalled Due to Temperature Exposure During Shipping
Hetero Labs Limited is recalling Valganciclovir Tablets 450 mg because they were exposed to high temperatures during shipping. The recall covers 1,764 bottles distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically indicates a situation where use of the product may cause temporary or medically reversible health consequences. The hazard is temperature abuse, which is a quality control issue rather than a direct toxicological hazard, and no illnesses or injuries are reported in the source text.
Plain-English summary
Hetero Labs Limited Unit V is recalling 1,764 bottles of Valganciclovir Tablets USP 450 mg. The recall was initiated because the medication was exposed to higher temperatures at an airport or in cargo. This exposure occurred in the same consignment as a complaint batch of Famciclovir.
The affected product is Valganciclovir Tablets USP 450 mg, 60-count bottles, manufactured for Camber Pharmaceuticals, Inc. The specific lots involved are VGC17040 and VGC17041, with an expiration date of 07/2019. The product was distributed in New Jersey and then nationwide in the USA.
Consumers should check their medication for the lot numbers VGC17040 or VGC17041 and an expiration date of 07/2019. If the product matches these details, consumers should stop using it and contact their healthcare provider or pharmacist for guidance on replacement or disposal.
The recalled product
- Product
- VALGANCICLOVIR (VALGANCICLOVIR)
- Brand
- VALGANCICLOVIR
- Manufacturer
- Hetero Labs Limited Unit V
- Category
- Drug — Antiviral
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #s VGC17040 & VGC17041
- EXP 07/2019
UPCs (1)
- 0331722832601
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Hetero Labs Limited Unit V under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Hetero Labs Limited Unit V
See all →- ModeratePantoprazole Sodium Tablets Recalled for Discoloration Issues
FDA (Drugs) · 2026-04-29
- ModerateHetero Labs Recalls Losartan Potassium Tablets Due to Bulging Complaints
FDA (Drugs) · 2020-09-02
- CriticalHetero Labs Recalls Montelukast Sodium Tablets Due to Labeling Error
FDA (Drugs) · 2018-10-03
- ModerateHetero Recalls Montelukast Sodium Tablets Due to Blue Specks
FDA (Drugs) · 2018-10-03
- SevereHetero Labs Recalls Valsartan Tablets Due to Carcinogen Impurity
FDA (Drugs) · 2018-08-29
Same hazard · temperature abuse
See all →- ModerateGemcitabine Injection Recalled Due to Temperature Storage Abuse
FDA (Drugs) · 2026-07-08
- ModerateGarland Fresh peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- ModerateChristopher Ranch peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- SevereCrab Cakes Sold to Food Service Recalled for Botulism Risk
FDA (Food) · 2026-04-15
- CriticalUDENYCA syringes recalled after cartons were stored at room temperature
FDA (Drugs) · 2026-02-18